De Rie, MA, et al. “Soluble Interleukin-2 Receptor (sIL-2R) Is a Marker of Disease Activity in Psoriasis: A Comparison of SIL-2R, sCD27, sCD4, SCD8 and SICAM-1”. Acta Dermato-Venereologica, vol. 76, no. 5, Sept. 1996, pp. 357-60, doi:10.2340/0001555576357360.